(Q38868393)

7 September 2017

1 reference

title

Health Care Disparities in Hereditary Ovarian Cancer: Are We Reaching the Underserved Population? (English)

1 reference

7 September 2017

0 references

0 references

1 reference

Thomas C Randall

1

1 reference

7 September 2017

Katrina Armstrong

series ordinal

2

1 reference

7 September 2017

publication date

1 August 2016

1 reference

Current Treatment Options in Oncology

7 September 2017

published in

1 reference

7 September 2017

volume

17

1 reference

7 September 2017

issue

8

1 reference

7 September 2017

page(s)

39

1 reference

7 September 2017

cites work

Cancer statistics, 2015

1 reference

https://api.crossref.org/works/10.1007%2FS11864-016-0417-1

Racial differences in stage at diagnosis and survival from epithelial ovarian cancer: a fundamental cause of disease approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-016-0417-1

Current understanding of the epidemiology and clinical implications of BRCA1 and BRCA2 mutations for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-016-0417-1

Meta-analysis of BRCA1 and BRCA2 penetrance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-016-0417-1

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-016-0417-1

Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-016-0417-1

International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-016-0417-1

Effect of Screening on Ovarian Cancer Mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-016-0417-1

Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-016-0417-1

Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-016-0417-1

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-016-0417-1

Serous tubal intraepithelial carcinoma: diagnostic reproducibility and its implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-016-0417-1

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-016-0417-1

Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-016-0417-1

Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-016-0417-1

BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-016-0417-1

Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-016-0417-1

BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-016-0417-1

Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-016-0417-1

Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-016-0417-1

Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-016-0417-1

A high frequency of BRCA mutations in young black women with breast cancer residing in Florida

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-016-0417-1

Deleterious BRCA1/2 mutations in an urban population of Black women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-016-0417-1

Increased uptake of BRCA1/2 genetic testing among African American women with a recent diagnosis of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-016-0417-1

Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-016-0417-1

American BRCA Outcomes and Utilization of Testing (ABOUT) study: a pragmatic research model that incorporates personalized medicine/patient-centered outcomes in a real world setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-016-0417-1

Breast cancer risk reduction options: awareness, discussion, and use among women from four ethnic groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-016-0417-1

A randomized, controlled trial to increase discussion of breast cancer in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-016-0417-1

Addressing social determinants of health to improve access to early breast cancer detection: results of the Boston REACH 2010 Breast and Cervical Cancer Coalition Women's Health Demonstration Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-016-0417-1

Multiple barriers delay care among women with abnormal cancer screening despite patient navigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-016-0417-1

Patient navigation to improve follow-up of abnormal mammograms among disadvantaged women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-016-0417-1

Patient navigation: the promise to reduce health disparities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-016-0417-1

Bridging the gap: a community health program saved lives, then closed its doors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-016-0417-1

“BRCAness” Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated WithBRCA1andBRCA2Mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-016-0417-1

Prevalence and Predictors ofBRCA1andBRCA2Mutations in a Population-Based Study of Breast Cancer in White and Black American Women Ages 35 to 64 Years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-016-0417-1

Frequency of breast cancer attributable to BRCA1 in a population-based series of American women

21 January 2018

1 reference

12 December 2020

Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast Cancer

1 reference

12 December 2020

Assessing the impact of patient navigation: prevention and early detection metrics

1 reference

12 December 2020

Clinical and Pathological Features of Ovarian Cancer in Women with Germ-Line Mutations ofBRCA1

1 reference

12 December 2020

Effect of Patient Navigation on Breast Cancer Screening Among African American Medicare Beneficiaries: A Randomized Controlled Trial

1 reference

12 December 2020

History and principles of patient navigation

1 reference

12 December 2020

Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer

1 reference

12 December 2020

10.1007/S11864-016-0417-1

Identifiers

DOI

1 reference

Dimensions Publication ID

7 September 2017

1042639068

0 references

1 reference